Telix Pharmaceuticals (Belgium)

{
  "events": [
    {
      "kind": "director_out",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Darren C. Smith",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": "de_plein_droit_dissolution",
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2025-12-31",
      "evidence_quote": "L\u0027Actionnaire prend note et accepte pour autant que de besoin, la d\u00E9mission de M. Darren C. Smith de son mandat d\u0027administrateur de la Soci\u00E9t\u00E9 avec effet au 31 d\u00E9cembre 2025.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "director_in",
      "role": "administrateur",
      "person": {
        "rrn": null,
        "name": "Caroline Defraiteur",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": null,
      "via_org": null,
      "statutory": "statutair",
      "compensated": false,
      "effective_date": "2025-12-31",
      "evidence_quote": "l\u0027Actionnaire d\u00E9cide de nommer Mme Caroline Defraiteur, de nationalit\u00E9 belge, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, prenant effet \u00E0 partir du 31 d\u00E9cembre 2025 et pour une dur\u00E9e ind\u00E9termin\u00E9e.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "fr",
    "pub_date": null,
    "filing_date": "2025-12-19",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "enig_aandeelhouder_schriftelijk",
      "date": "2025-12-19",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "Telix Pharmaceuticals (Belgium)",
    "legal_form": "SRL"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Raphael Ortiz",
    "org_rep_person_name": null,
    "person_role_at_subject": "Administrateur"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "commissaris_out",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BDO R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "L\u0027Actionnaire prend note de, et accepte, pour autant que de besoin, la d\u00E9mission de BDO R\u00E9viseurs d\u0027Entreprises SRL en tant que commissaire de la Soci\u00E9t\u00E9.",
      "discharge_granted": true
    },
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "M\u00E9lanie Adorante",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "PwC R\u00E9viseurs d\u0027Entreprises SRL",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027Actionnaire d\u00E9cide d\u0027\u00E9lire PwC R\u00E9viseurs d\u0027Entreprises SRL, dont le si\u00E8ge est situ\u00E9 \u00E0 1831 Diegem. Culliganlaan 5, repr\u00E9sent\u00E9e par Madame M\u00E9lanie Adorante, r\u00E9viseur d\u0027entreprises, en tant que commissaire de la Soci\u00E9t\u00E9, pour une dur\u00E9e de trois ans (et plus particuli\u00E8rement, les exercices sociaux 20"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "TELIX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Melanie FARRIS",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-08-15",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de r\u00E9voquer, avec effet imm\u00E9diat, le mandat d\u0027administrateur de la Soci\u00E9t\u00E9 des personnes suivantes: -Madame Melanie FARRIS, domicili\u00E9e \u00E0...; et -L\u0027actionnaire unique le remercie pour ses services.",
      "discharge_granted": true
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Richard VALEIX",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-08-15",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de r\u00E9voquer, avec effet imm\u00E9diat, le mandat d\u0027administrateur de la Soci\u00E9t\u00E9 des personnes suivantes: -Madame Melanie FARRIS, domicili\u00E9e \u00E0...; et -Monsieur Richard VALEIX, domicili\u00E9 \u00E0 .... L\u0027actionnaire unique le remercie pour ses services.",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Raphael ORTIZ",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-08-15",
      "evidence_quote": "L\u0027actionnaire unique d\u00E9cide de nommer Monsieur Raphael ORTIZ, ..., en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "TELIX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Douglas Cubbin",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-07-31",
      "evidence_quote": "L\u0027Actionnaire prend note de et accepte, pour autant que de besoin, la d\u00E9mission de M. Douglas Cubbin en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 avec effet au 31 juillet 2022."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Darren C. Smith",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2022-07-31",
      "evidence_quote": "L\u0027Actionnaire confirme la nomination, avec effet au 31 juillet 2022, de M. Darren C. Smith, de nationalit\u00E9 australienne, ayant \u00E9lu domicile au si\u00E8ge de la Soci\u00E9t\u00E9, en tant qu\u0027administrateur de la Soci\u00E9t\u00E9 pour une dur\u00E9e ind\u00E9termin\u00E9\u00E9."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "TELIX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "SRL"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "C\u00E9dric ANTONELLI",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "BDO R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-08-31",
      "evidence_quote": "Sur proposition du Conseil d\u0027Administration, l\u0027Assembl\u00E9e d\u00E9cide \u00E0 l\u0027unanimit\u00E9 de nommer, avec effet r\u00E9troactif au 31/08/2021 et pour une dur\u00E9e de3 ans, en qualit\u00E9 de Commissaire pour les comptes statutaires la soci\u00E9t\u00E9 civile sous forme de SRL \u00AB BDO R\u00E9viseurs d\u0027Entreprises \u003E (agr\u00E9ment n\u00B0 \u0412 00023), qu"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "TELIX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "SRL"
  }
}

{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2022-02-02",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "TELIX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "SPRL"
  },
  "signature_regime": "solo",
  "special_mandates": [
    {
      "quote": "au notaire soussign\u00E9 pour l\u2019\u00E9tablissement et le d\u00E9p\u00F4t d\u2019une version coordonn\u00E9e des statuts. A ces fins, chaque mandataire pourra au nom de la soci\u00E9t\u00E9, faire toutes d\u00E9clarations, signer tous documents et pi\u00E8ces et, en g\u00E9n\u00E9ral, faire le n\u00E9cessaire.",
      "holder_kbo": "0890.388.338",
      "holder_name": "G\u00E9rard INDEKEU",
      "scope_categories": [
        "filing",
        "publication"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Herstal",
        "region": null,
        "street": "Rue de Herm\u00E9e",
        "country": "BE",
        "postcode": "4040",
        "box_number": null,
        "street_number": "255"
      },
      "old_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "All\u00E9e du Six-Ao\u00FBt",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "8"
      },
      "effective_date": "2020-01-23",
      "evidence_quote": "Les g\u00E9rants d\u00E9cident de transf\u00E9rer le si\u00E8ge social de la SPRL TELIX PHARMACEUTICALS (BELGIUM), du All\u00E9e du Six-Ao\u00FBt 8 \u00E0 4000 Li\u00E8ge au Rue de Herm\u00E9e 255 \u00E0 4040 Herstal \u00E0 compter du 23 janvier 2020."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "TELIX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "SPRL"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Ludovic Wouters",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0719281031",
        "name": "BRINGING 2 BUSINESS",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire d\u00E9cide de nommer, en qualit\u00E9 de g\u00E9rant, en remplacement de la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e POTENTIAL 4 GROWTH (P4G), inscrite \u00E0 la BCE sous le num\u00E9ro 0647.923.079, dont le si\u00E8ge social se situe avenue Daniel Boon 64, \u00E0 1160 Auderghem, repr\u00E9sent\u00E9e par so"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "TELIX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "SPRL"
  }
}

{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Li\u00E8ge",
        "region": null,
        "street": "All\u00E9e du 6 Ao\u00FBt",
        "country": "BE",
        "postcode": "4000",
        "box_number": null,
        "street_number": "8"
      },
      "old_address": {
        "city": "Etterbeek",
        "region": null,
        "street": "Boulevard Saint-Michel",
        "country": "BE",
        "postcode": "1040",
        "box_number": null,
        "street_number": "47"
      },
      "effective_date": "2019-04-15",
      "evidence_quote": "A partir du 15 avril 2019, le si\u00E8ge social de la SPRL TELIX Pharmaceuticals sera transf\u00E9 du Boulevard Saint-Michel 47 \u00E0 1040 Etterbeek au 8, All\u00E9e du 6 Ao\u00FBt \u00E0 4000 Li\u00E8ge."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "TELIX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "SPRL"
  }
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Cedric Antonelli",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0431088289",
        "name": "BDO R\u00E9viseurs d\u0027Entreprises",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale nomme la soci\u00E9t\u00E9 coop\u00E9rative \u00E0 responsabilit\u00E9 limit\u00E9e BDO R\u00E9viseurs d\u0027Entreprises, repr\u00E9sent\u00E9e par Cedric Antonelli, sise avenue Da Vinci 9 \u00E0 1930 Zaventem, inscrite \u00E0 la BCE sous le num\u00E9ro 0431.088.289 en qualit\u00E9 de commissaire pour une p\u00E9riode de trois ans prenant son terme \u00E0 "
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "TELIX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "SPRL"
  }
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Odile Jaume",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": "0647923079",
        "name": "POTENTIAL 4 GROWTH (P4G)",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire d\u00E9cide de nommer, en qualit\u00E9 de g\u00E9rant, en remplacement de madame Odile Jaume, la soci\u00E9t\u00E9 priv\u00E9e \u00E0 responsabilit\u00E9 limit\u00E9e POTENTIAL 4 GROWTH (P4G), inscrite \u00E0 la BCE sous le num\u00E9ro 0647.923.079, dont le si\u00E8ge social se situe avenue Daniel Boon 64, \u00E0 1160 Auderghem"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "TELIX PHARMACEUTICALS (BELGIUM)",
    "legal_form": "SPRL"
  }
}

{
  "kind": "oprichting",
  "seat": "Boulevard Saint-Michel 47, 1040 Etterbeek",
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "founders": [
    {
      "org": {
        "kbo": "0692.570.595",
        "name": "Telix International Pty Ltd"
      },
      "kind": "rechtspersoon",
      "person": null,
      "share_class": "Ordinary",
      "partner_role": null,
      "holder_org_kbo": "0692.570.595",
      "holder_org_name": "Telix International Pty Ltd",
      "contribution_type": "cash",
      "amount_paid_in_eur": 12400,
      "holder_person_name": null,
      "is_subscriber_only": true,
      "n_shares_subscribed": 100,
      "amount_subscribed_eur": 18550,
      "is_anonymous_silent_partner": false
    }
  ],
  "capital_eur": 18550,
  "subject_company": {
    "kbo": "0695.832.765",
    "name_full": "Telix Pharmaceuticals (Belgium)",
    "legal_form": "SRL"
  },
  "initial_directors": [],
  "incorporation_date": "2018-05-07",
  "post_incorporation_mandates": []
}